deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT05394558

AsiDNA Children, Adolescents and Young Adults (AsiDNA)

A Phase Ib/II Study on AsiDNA in Association With Re-irradiation in Children, Adolescents and Young Adults With High-grade Glioma

Sponsor: Institut Curie

Conditions Recurrent High-grade Glioma
Interventions AsiDNA
Updated 7 times since 2022 Last updated: Dec 19, 2023 Started: May 27, 2022 Primary completion: Sep 20, 2023 Completion: Sep 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

IDMC recommendations

Other terminated trials from Institut Curie

See all terminations from Institut Curie

This PHASE1/PHASE2 trial investigates Recurrent High-grade Glioma and is currently terminated or withdrawn. Institut Curie leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2022 – ~Sep 2022 · 3 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshotRecruiting~Aug 2023 – ~Nov 2023 · 3 months · monthly snapshot~Nov 2023 – ~Jan 2024 · 2 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2024 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Nov 2023 — Jan 2024 [monthly]

    Terminated PHASE1_PHASE2

    Status: Suspended → Terminated

  5. Aug 2023 — Nov 2023 [monthly]

    Suspended PHASE1_PHASE2

    Status: Recruiting → Suspended

▶ Show 2 earlier versions

  1. Sep 2022 — Aug 2023 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Active Not Recruiting → Recruiting

  2. Jun 2022 — Sep 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut Curie
Data source: Institut Curie

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations